Active, not recruitingNCT04149600
Identification of Genetic Causes of Calcific Aortic Valve Disease
Studying Familial bicuspid aortic valve
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beth Israel Deaconess Medical Center
- Intervention
- Patients scheduled to undergo aortic valve replacement or aortic surgery at BIDMC will be approached for participation in this study.(procedure)
- Enrollment
- 1000 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 2018 – 2027
Study locations (1)
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Collaborators
Brigham and Women's Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04149600 on ClinicalTrials.govOther trials for Familial bicuspid aortic valve
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06869954Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial - a Randomized TrialUniversity Hospital Augsburg
- RECRUITINGNCT06830499Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From ChinaXijing Hospital
- RECRUITINGNANCT06817148Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot TrialCedars-Sinai Medical Center
- RECRUITINGNCT06802016A Study of Chinese Congenital Bicuspid Aortic ValveRuijin Hospital
- RECRUITINGNCT06657911Size Up Bicuspid with the LIra MEthod: the SUBLIME StudyIRCCS San Raffaele
- RECRUITINGNANCT06688448Valvular Assessment of New Generation Aortic Replacement DevicesInstituto Dante Pazzanese de Cardiologia
- RECRUITINGNCT06153407Genetic Test Based Risk Prediction of Early Calcific Aortic Valve Disease in Patients With Bicuspid Aortic ValveYonsei University
- ENROLLING BY INVITATIONNCT06212050Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic StenosisNational University of Ireland, Galway, Ireland